ProMetic Life Sciences (OTCMKTS:PFSCF) Trading Down 3.6%

ProMetic Life Sciences Inc. (OTCMKTS:PFSCF) traded down 3.6% on Wednesday . The company traded as low as $5.47 and last traded at $5.47. 200 shares were traded during trading, a decline of 28% from the average session volume of 279 shares. The stock had previously closed at $5.67.

The business has a fifty day simple moving average of $5.47 and a two-hundred day simple moving average of $5.47.

About ProMetic Life Sciences (OTCMKTS:PFSCF)

Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.

Further Reading: What is a trade deficit?

Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.